Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Clemens

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
European Neurology|January 1, 1994
Gene therapy prospects for Duchenne muscular dystrophyP R Clemens, C T Caskey
Current Neurology and Neuroscience Reports|March 20, 2002
Progress in gene therapy for Duchenne muscular dystrophyP R Clemens, F J Duncan
Current Opinion in Rheumatology|November 1, 1996
HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies, and merosinopathiesE P Hoffman, P R Clemens
Annals of Neurology|October 1, 1990
Adult phosphorylase b kinase deficiencyP R Clemens, M Yamamoto, A G Engel
Neurology|November 1, 1991
Mitochondrial DNA deletions in mitochondrial cytopathies: observations in 19 patientsM Yamamoto, P R Clemens, A G Engel
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2001
Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNAF Liu, M Nishikawa, P R Clemens, et al.
Gene Therapy|May 29, 2009
Systemic delivery of AAV8 in utero results in gene expression in diaphragm and limb muscle: treatment implications for muscle disordersB M Koppanati, J Li, X Xiao, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 27, 1993
Gene transfer therapy for heritable disease: cell and expression targetingK Mitani, P R Clemens, A B Moseley, et al.
Human Molecular Genetics|November 1, 1994
Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunitM Wehner, P R Clemens, A G Engel, et al.
Gene Therapy|July 23, 2004
CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscleZ Jiang, G Schiedner, S C Gilchrist, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
European Neurology|January 1, 1994
Gene therapy prospects for Duchenne muscular dystrophyP R Clemens, C T Caskey
Current Neurology and Neuroscience Reports|March 20, 2002
Progress in gene therapy for Duchenne muscular dystrophyP R Clemens, F J Duncan
Current Opinion in Rheumatology|November 1, 1996
HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies, and merosinopathiesE P Hoffman, P R Clemens
Annals of Neurology|October 1, 1990
Adult phosphorylase b kinase deficiencyP R Clemens, M Yamamoto, A G Engel
Neurology|November 1, 1991
Mitochondrial DNA deletions in mitochondrial cytopathies: observations in 19 patientsM Yamamoto, P R Clemens, A G Engel
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2001
Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNAF Liu, M Nishikawa, P R Clemens, et al.
Gene Therapy|May 29, 2009
Systemic delivery of AAV8 in utero results in gene expression in diaphragm and limb muscle: treatment implications for muscle disordersB M Koppanati, J Li, X Xiao, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 27, 1993
Gene transfer therapy for heritable disease: cell and expression targetingK Mitani, P R Clemens, A B Moseley, et al.
Human Molecular Genetics|November 1, 1994
Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunitM Wehner, P R Clemens, A G Engel, et al.
Gene Therapy|July 23, 2004
CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscleZ Jiang, G Schiedner, S C Gilchrist, et al.
Pageof 4